Pittsburgh, PA, United States of America

Nahathai Charukamnoetkanok

This inventor holds 2 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nahathai Charukamnoetkanok. Retrieved from https://idiyas.com/inventor/nahathai-charukamnoetkanok

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nahathai Charukamnoetkanok: Innovator in Crystalline Compounds

Introduction

Nahathai Charukamnoetkanok is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of chemistry, particularly in the development of crystalline compounds. With a total of 2 patents to his name, his work is recognized for its innovative approaches and applications.

Latest Patents

Charukamnoetkanok's latest patents include two distinct crystalline compounds. The first patent is for a crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolate. This compound is characterized in the monoclinic crystal system and P2/n space group. It is measured with radiation at 0.7107 Å, with lattice parameters a, b, and c of 5.0318 ű0.006 Å, 23.684 ű0.002 Å, and 18.877 ű0.002 Å, respectively, and β of 90.703±0.003. The patent also discloses methods of making the compound, compositions comprising it, and methods of treatment using it.

The second patent is for a crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea benzenesulfonate. This compound is characterized in the triclinic crystal system and P-1 space group. It is also measured with radiation at 0.7107 Å, with lattice parameters a, b, and c of 7.800 ű0.001 Å, 13.406 ű0.002 Å, and 13.554 ű0.002 Å, respectively. The angles α, β, and γ are 67.155±0.002, 79.724±0.002, and 84.067±0.002, respectively. Similar to the first patent, it includes ways to make the compound, compositions comprising it, and methods of treatment using it.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…